Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms.

Alcock J, Maley CC, Aktipis CA.

Bioessays. 2014 Oct;36(10):940-9. doi: 10.1002/bies.201400071. Epub 2014 Aug 8. Review.

2.

Microbiota-Gut-Brain Axis: Modulator of Host Metabolism and Appetite.

van de Wouw M, Schellekens H, Dinan TG, Cryan JF.

J Nutr. 2017 May;147(5):727-745. doi: 10.3945/jn.116.240481. Epub 2017 Mar 29. Review.

PMID:
28356427
3.

Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.

Liu X, Cao S, Zhang X.

J Agric Food Chem. 2015 Sep 16;63(36):7885-95. doi: 10.1021/acs.jafc.5b02404. Epub 2015 Sep 1. Review.

PMID:
26306709
4.

'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.

Tuohy KM, Fava F, Viola R.

Proc Nutr Soc. 2014 May;73(2):172-85. doi: 10.1017/S0029665113003911. Epub 2014 Feb 4. Review.

PMID:
24495527
5.

Genes, emotions and gut microbiota: The next frontier for the gastroenterologist.

Panduro A, Rivera-Iñiguez I, Sepulveda-Villegas M, Roman S.

World J Gastroenterol. 2017 May 7;23(17):3030-3042. doi: 10.3748/wjg.v23.i17.3030. Review.

6.

Gut microbiota, the pharmabiotics they produce and host health.

Patterson E, Cryan JF, Fitzgerald GF, Ross RP, Dinan TG, Stanton C.

Proc Nutr Soc. 2014 Nov;73(4):477-89. doi: 10.1017/S0029665114001426. Epub 2014 Sep 8. Review.

PMID:
25196939
7.

Gut bacterial microbiota and obesity.

Million M, Lagier JC, Yahav D, Paul M.

Clin Microbiol Infect. 2013 Apr;19(4):305-13. doi: 10.1111/1469-0691.12172. Epub 2013 Mar 2. Review.

8.

The gut microbiota, obesity and insulin resistance.

Shen J, Obin MS, Zhao L.

Mol Aspects Med. 2013 Feb;34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16. Review.

PMID:
23159341
9.

Prebiotic effects: metabolic and health benefits.

Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Léotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A.

Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363. Review.

PMID:
20920376
10.

Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?

Esteve E, Ricart W, Fernández-Real JM.

Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d. Review.

PMID:
21681087
11.

The brain's Geppetto-microbes as puppeteers of neural function and behaviour?

Stilling RM, Dinan TG, Cryan JF.

J Neurovirol. 2016 Feb;22(1):14-21. doi: 10.1007/s13365-015-0355-x. Epub 2015 Jun 6. Review.

PMID:
26047662
12.

Gut microbiota in obesity and metabolic disorders.

Sanz Y, Santacruz A, Gauffin P.

Proc Nutr Soc. 2010 Aug;69(3):434-41. doi: 10.1017/S0029665110001813. Epub 2010 Jun 14.

PMID:
20540826
13.

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

Diamant M, Blaak EE, de Vos WM.

Obes Rev. 2011 Apr;12(4):272-81. doi: 10.1111/j.1467-789X.2010.00797.x. Epub 2010 Aug 26. Review.

PMID:
20804522
14.

Antibiotics, probiotics and prebiotics in IBD.

Bernstein CN.

Nestle Nutr Inst Workshop Ser. 2014;79:83-100. doi: 10.1159/000360713. Epub 2014 Sep 5. Review.

PMID:
25227297
15.

Understanding the role of gut microbes and probiotics in obesity: how far are we?

Sanz Y, Rastmanesh R, Agostoni C.

Pharmacol Res. 2013 Mar;69(1):144-55. doi: 10.1016/j.phrs.2012.10.021. Epub 2012 Nov 9. Erratum in: Pharmacol Res. 2013 May;71:69. Agostonic, Carlo [corrected to Agostoni, Carlo].

PMID:
23147032
16.

Prebiotics, faecal transplants and microbial network units to stimulate biodiversity of the human gut microbiome.

Van den Abbeele P, Verstraete W, El Aidy S, Geirnaert A, Van de Wiele T.

Microb Biotechnol. 2013 Jul;6(4):335-40. doi: 10.1111/1751-7915.12049. Epub 2013 Apr 18. Review.

17.

Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota.

Cani PD, Delzenne NM.

Curr Opin Pharmacol. 2009 Dec;9(6):737-43. doi: 10.1016/j.coph.2009.06.016. Epub 2009 Jul 21. Review.

PMID:
19628432
18.

Microbiota regulation of the Mammalian gut-brain axis.

Burokas A, Moloney RD, Dinan TG, Cryan JF.

Adv Appl Microbiol. 2015;91:1-62. doi: 10.1016/bs.aambs.2015.02.001. Epub 2015 Mar 11. Review.

PMID:
25911232
19.

Targeting gut microbiota as a possible therapy for diabetes.

He C, Shan Y, Song W.

Nutr Res. 2015 May;35(5):361-7. doi: 10.1016/j.nutres.2015.03.002. Epub 2015 Mar 14. Review.

PMID:
25818484
20.

The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies.

West CE, Renz H, Jenmalm MC, Kozyrskyj AL, Allen KJ, Vuillermin P, Prescott SL; in-FLAME Microbiome Interest Group.

J Allergy Clin Immunol. 2015 Jan;135(1):3-13; quiz 14. doi: 10.1016/j.jaci.2014.11.012. Review.

Supplemental Content

Support Center